Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Abroad (travel likely)RecruitingPHASE2
Conditions
Friedreich Ataxia · Cardiomyopathy, Secondary
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of South Florida, Tampa, Florida, United States
Study leads
Lexeo Clinical Trials
Study Director
Lexeo Therapeutics, Inc.